Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT03957746
  4. Details
NCT03957746 Clinical Trial

Set Volume of Optimal Resistance Exercise to Generate Hypotension

Hypertension Clinical Trial

Official title:
Set Volume of Optimal Resistance Exercise to Generate Hypotension in Hypertensive Elderly Subjects: a Crossover Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03957746
Other study ID # 000018819
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 13, 2020
Est. completion date October 3, 2021

Study information
Verified date October 2021
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the volume of optimal resistance exercise to generate postexercise hypotension after performing a single exercise in hypertensive elderly subjects. 20 subjects will perform 1 control session and 3 resistance training sessions with different volume: 3, 6 and 9 sets

Recruitment information / eligibility
Status Completed
Enrollment 19
Est. completion date October 3, 2021
Est. primary completion date October 1, 2020
Accepts healthy volunteers No
Gender All
Age group 55 Years to 70 Years
Eligibility Inclusion Criteria: - Hypertensive subjects treated with antihypertensive medication - Controlled blood pressure - Age between 55 and 70 years old - Sedentary (less than 150 minutes per week of moderate physical activity and/or 75 minutes per week of vigorous physical activity) - Non-smokers - Non-alcoholics - Informed consent Exclusion Criteria: - Any kidney, lung, neurological or psychiatric disease - Unable to perform exercises - Participation in other physical activity programs during the study or in the previous 3 months

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Resistance training
3, 6 or 9 sets of biceps curl with elastic bands at 20 repetition-maximum (RM)

Locations
Country Name City State
Spain Primary Health-Care Center Rocafort Valencia

Sponsors (1)
Lead Sponsor Collaborator
University of Valencia

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Blood pressure Baseline
Primary Blood pressure Immediately after the end of resistance training session
Primary Blood pressure 30 minutes after the end of resistance training session
Primary Blood pressure 60 minutes after the end of resistance training session
Primary Blood pressure 4 hours after the end of resistance training session
Primary Blood pressure 5 hours after the end of resistance training session
Primary Blood pressure 6 hours after the end of resistance training session
Secondary Heart rate Baseline
Secondary Heart rate Immediately after the end of resistance training session
Secondary Heart rate 30 minutes after the end of resistance training session
Secondary Heart rate 60 minutes after the end of resistance training session
Secondary Heart rate 4 hours after the end of resistance training session
Secondary Heart rate 5 hours after the end of resistance training session
Secondary Heart rate 6 hours after the end of resistance training session
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A